Literature DB >> 3876560

Monoclonal antibodies against human Ia antigens stimulate monocytes to secrete interleukin 1.

R Palacios.   

Abstract

The monoclonal antibodies (mAb) DA6.147, DA6.164, and HIG.48 against human Ia antigens, but not the W6/32 mAb against human class I major histocompatibility complex antigens or the anti-monocyte OKM1 and 63D3 mAb, stimulated monocytes to secrete interleukin 1 (IL-1). IL-1 was measured by its property of promoting the production of interleukin 2 (IL-2) by phytohemagglutinin-treated LBRM-33 clone 1A5 cells. IL-1 activity induced by anti-Ia antibodies could be detected 24 hr after initiation of the cultures and reached its highest levels at days 3-4 of culture. Concentrations of 1 microgram/ml or higher of the anti-Ia antibodies induced monocytes to secrete significant levels of IL-1 activity. The anti-Ia mAb induced Ia-bearing but not Ia-negative monocytes to secrete IL-1. Both Ia-positive and Ia-negative monocytes produced IL-1 activity under the stimulus of lipopolysaccharide. It is concluded that the DA6.147, DA6.164, and HIG.48 mAb stimulate secretion of IL-1 by interacting Ia antigens on monocytes. The data support the view that besides serving as restricting elements for recognition of foreign antigens by T cells, Ia antigens may also function as transducer elements.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3876560      PMCID: PMC391268          DOI: 10.1073/pnas.82.19.6652

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

Review 1.  MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

2.  Interpretation of the specificities of monoclonal antibodies recognising human MHC class II antigens.

Authors:  K Guy; C M Steel
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

Review 3.  The class II molecules of the human and murine major histocompatibility complex.

Authors:  J F Kaufman; C Auffray; A J Korman; D A Shackelford; J Strominger
Journal:  Cell       Date:  1984-01       Impact factor: 41.582

4.  Studies on the role of lymphocyte-activating factor (Interleukin 1) in antigen-induced lymph node lymphocyte proliferation.

Authors:  S B Mizel; A Ben-Zvi
Journal:  Cell Immunol       Date:  1980-09-01       Impact factor: 4.868

5.  A monoclonal antibody reactive with human peripheral blood monocytes.

Authors:  J Breard; E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

Review 6.  Major histocompatibility complex restricted cell-mediated immunity.

Authors:  G M Shearer; A M Schmitt-Verhulst
Journal:  Adv Immunol       Date:  1977       Impact factor: 3.543

7.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis.

Authors:  C J Barnstable; W F Bodmer; G Brown; G Galfre; C Milstein; A F Williams; A Ziegler
Journal:  Cell       Date:  1978-05       Impact factor: 41.582

8.  The syngeneic mixed leukocyte reaction: the genetic requirements for the recognition of self resemble the requirements for the recognition of antigen in association with self.

Authors:  U Yamashita; E M Shevach
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

9.  Lymphocyte transformation induced by autologous cells. V. Generation of immunologic memory and specificity during the autologous mixed lymphocyte reaction.

Authors:  M E Weksler; R Kozak
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

10.  Function of macrophages in antigen recognition by guinea pig T lymphocytes. I. Requirement for histocompatible macrophages and lymphocytes.

Authors:  A S Rosenthal; E M Shevach
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

View more
  10 in total

Review 1.  A novel, alternative pathway of apoptosis triggered through class II major histocompatibility complex molecules.

Authors:  Zoltan A Nagy; Nuala A Mooney
Journal:  J Mol Med (Berl)       Date:  2003-10-09       Impact factor: 4.599

2.  Glatiramer acetate triggers PI3Kδ/Akt and MEK/ERK pathways to induce IL-1 receptor antagonist in human monocytes.

Authors:  Rakel Carpintero; Karim J Brandt; Lyssia Gruaz; Nicolas Molnarfi; Patrice H Lalive; Danielle Burger
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

3.  Induction of HLA-DR antigen expression in human endometrial epithelial cells in vitro by recombinant gamma-interferon.

Authors:  S S Tabibzadeh; M A Gerber; P G Satyaswaroop
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

Review 4.  Modulation of the immune response with T-cell epitopes: the ultimate goal for specific immunotherapy of autoimmune disease.

Authors:  P J Fairchild; C J Thorpe; P J Travers; D C Wraith
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

Review 5.  Surface proteins and glycoproteins of human leucocytes.

Authors:  V Horejsí; V Bazil
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

6.  Langerhans' cell depletion by staphylococcal superantigens.

Authors:  S Pickard; G Shankar; K Burnham
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

7.  Anti-I-A antibody modulation of lymphocyte traffic in hapten-stimulated inbred mice.

Authors:  A M Carroll; M I Greene
Journal:  Immunology       Date:  1987-11       Impact factor: 7.397

8.  Induction of multinucleated giant cells from rheumatoid arthritis (RA) synovial adherent cells by anti-DR antibody.

Authors:  T Matsuyama; N Nakashima; T Matsuda; H Nakamura; S Uchida; T Abe
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

9.  Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9.

Authors:  Cécile Keryer-Bibens; Catherine Pioche-Durieu; Cécile Villemant; Sylvie Souquère; Nozomu Nishi; Mitsuomi Hirashima; Jaap Middeldorp; Pierre Busson
Journal:  BMC Cancer       Date:  2006-12-08       Impact factor: 4.430

10.  A fail-safe mechanism for maintaining self-tolerance.

Authors:  S Guerder; P Matzinger
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.